Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Progesterone Route and Endometriosis on Endometrial Receptivity
NCT03687021Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of progesterone in hypothalamic amenorrhea (HA) and primary ovarian insufficiency (POI) (5 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Endometrial Receptivity measured by Pathology at 3 months. Status: unknown.
02
Drugs
progesterone
03
Conditions
hypothalamic amenorrhea (HA)primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT03687021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03687021.